Ccdc39^b2b1735Clo

This ENU-induced mutation was isolated in a screen at the University of Pittsburgh. The molecular lesion is a T to A substitution at nucleotide +2 following coding nucleotide 357 (c.357+2T>A, NM_026222) in intron 3, changing splice donor site A-GT to A-GA (wich is assumed to be much less efficient or inactive). (J:175213) Additional incidental mutations were detected in sequencing for the causative mutation, Ccdc39b2b1735Clo, and may be present in stocks carrying this mutation.